Literature DB >> 3266360

Epidemiological and genetic aspects of IgM rheumatoid factors.

G Husby1, J T Gran, A Johannessen.   

Abstract

The occurrence of IgM rheumatoid factors (RF) was studied in a random sample of 8807 persons aged between 20 and 50 years in Tromsø, North Norway. Seropositivity for IgM RF was defined as a Waaler titre of 40 or more. A total prevalence of IgM RF of 1.36% was found, and a prevalence between 0.48-0.94% was found among the healthy persons, with no sex difference. Approximately 50% of IgM Rf positives are thus healthy. Only 11% of those with IgM RF suffered from rheumatoid arthritis. The majority of RF positive sera from healthy persons were low titred, and 81% of them converted to seronegativity in the course of 3.5 years. A low titred IgM RF appears rather harmless, while a high titre indicates a specific disease process. No association between IgM RF and DR4 could be found in healthy persons. The frequencies of Gm-allotypes a, b, e, f-n and x in healthy, RF positive individuals did not differ from the RF positive patients with RA, suggesting that the Gm-allotypes are not involved in the genetic pre-disposition for RA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266360     DOI: 10.3109/03009748809096765

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  3 in total

1.  Rheumatoid factor positivity increases all-cause and cancer mortality: a cohort study.

Authors:  Joong Kyong Ahn; Jiwon Hwang; Yoosoo Chang; Seungho Ryu
Journal:  Rheumatol Int       Date:  2017-05-17       Impact factor: 2.631

2.  Is rheumatoid factor useful in primary care? A retrospective cross-sectional study.

Authors:  Anne Miller; Kamal R Mahtani; Margaret A Waterfield; Anthony Timms; Siraj A Misbah; Raashid A Luqmani
Journal:  Clin Rheumatol       Date:  2013-03-21       Impact factor: 2.980

3.  Association of schistosomiasis with false-positive HIV test results in an African adolescent population.

Authors:  Dean B Everett; Kathy J Baisely; Ruth McNerney; Ian Hambleton; Tobias Chirwa; David A Ross; John Changalucha; Deborah Watson-Jones; Helena Helmby; David W Dunne; David Mabey; Richard J Hayes
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.